You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

OXACILLIN SODIUM - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for oxacillin sodium and what is the scope of patent protection?

Oxacillin sodium is the generic ingredient in four branded drugs marketed by Glaxosmithkline, Ani Pharms, Apothecon, Teva, Baxter Hlthcare, Elkins Sinn, Eugia Pharma Speclts, Fresenius Kabi Usa, Hospira, Istituto Bio Ita Spa, Piramal Critical, Sagent Pharms, Sandoz, Steriscience Speclts, Watson Labs Inc, and Wockhardt Bio Ag, and is included in thirty-one NDAs. Additional information is available in the individual branded drug profile pages.

There are thirty-two drug master file entries for oxacillin sodium. Six suppliers are listed for this compound.

Summary for OXACILLIN SODIUM
US Patents:0
Tradenames:4
Applicants:16
NDAs:31
Drug Master File Entries: 32
Finished Product Suppliers / Packagers: 6
Raw Ingredient (Bulk) Api Vendors: 126
Clinical Trials: 2
Patent Applications: 6,473
What excipients (inactive ingredients) are in OXACILLIN SODIUM?OXACILLIN SODIUM excipients list
DailyMed Link:OXACILLIN SODIUM at DailyMed
Recent Clinical Trials for OXACILLIN SODIUM

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Haining Health-Coming Biotech Co., Ltd.Phase 2
Alphacait, LLCPhase 2
Fundação de Amparo à Pesquisa do Estado de São PauloPhase 4

See all OXACILLIN SODIUM clinical trials

Pharmacology for OXACILLIN SODIUM
Medical Subject Heading (MeSH) Categories for OXACILLIN SODIUM

US Patents and Regulatory Information for OXACILLIN SODIUM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glaxosmithkline BACTOCILL oxacillin sodium FOR SOLUTION;ORAL 062321-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Istituto Bio Ita Spa OXACILLIN SODIUM oxacillin sodium INJECTABLE;INJECTION 062798-002 Dec 11, 1995 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Istituto Bio Ita Spa OXACILLIN SODIUM oxacillin sodium INJECTABLE;INJECTION 062798-001 Dec 11, 1995 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Sandoz OXACILLIN SODIUM oxacillin sodium INJECTABLE;INJECTION 061490-004 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Apothecon PROSTAPHLIN oxacillin sodium CAPSULE;ORAL 050118-002 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Piramal Critical OXACILLIN SODIUM oxacillin sodium INJECTABLE;INJECTION 206681-002 Sep 11, 2017 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.